- Price
- $396.08
- Day
- +5.69%
- Mkt Cap
- $25.82B
- 52W Range
- $275.05 – $414.15
- Volume
- 1.66M
- Beta
- 1.18
Find a company by name or ticker and open its page
Breaking news, press releases, and analyst updates.
Most recent articles and analysis covering this company.
Waters Corporation (WAT) Q2 2026 Earnings Call Transcript
Read full article
Waters Corp (WAT) released its 8-K filing on August 4, 2026, presenting a robust performance for the second quarter of 2026 that surpassed analyst expectations
Read full article
Second Quarter 2026 Highlights Total reported revenue of $1.645 billion surpassed the high end of the guidance range, driven by broad-based outperformance across both organic revenue and the acquired businesses. Organic revenue of $828 million grew 7% as reported and 9% in constant currency; the Analytical Sciences Division (ASD) delivered 8% instrument growth and double-digit chemistry consumables growth, led by low-double-digit growth in both Pharma and A&G end markets, in constant currency, as the market recovery has entered a broader phase, expanding across additional customer segments.
Read full article
Waters (WAT) came out with quarterly earnings of $3.05 per share, beating the Zacks Consensus Estimate of $3.01 per share. This compares to earnings of $2.95 per share a year ago.
Read full article
The top five contributors for the quarter were MKS, Amphenol, Arista Networks, Bio-Techne, and Waters. The bottom five detractors for the quarter were Ross Stores, Arch Capital, Copart, Gartner, and Brown & Brown. We purchased shares in Verisk Analytics, the dominant provider of data and analytics to property and casualty insurers in the U.S.
Read full article
Waters (WAT) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Read full article
Brings Xevo™ TQ Absolute XR Mass Spectrometer's industry-leading tandem quadrupole MS sensitivity to clinical applications across women's health, cancer assessment, and toxicology. Offers 5x greater sensitivity vs.
Read full article
Waters (WAT) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Read full article
Assetmark Inc. lifted its holdings in Waters Corporation (NYSE: WAT) by 440.3% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 9,645 shares of the medical instruments supplier's stock after acquiring an additional 7,860 shares during the quarter. Assetmark Inc.'s holdings in
Read full article
The Swiss company agreed with Platinum Equity to create a joint venture and sell a 50% stake in its Waters and Beverages unit.
Read full article
SEATTLE--(BUSINESS WIRE)--PitchBook, a leading private capital market intelligence platform, today announced it has been named “Best Alternative Data Provider” in the Waters Technology Rankings 2026. The award, presented by Waters Technology, a leading publication covering financial technology and data for global capital markets, was decided by crowd-sourced votes from industry professionals across the capital markets technology sector. The Waters Technology Rankings recognize service providers.
Read full article